← Back to Search

PET-MRI Imaging for Esophageal Cancer

N/A
Recruiting
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial will test if PET-MRI imaging can be used to improve radiation treatment for esophageal cancer patients by getting MRI and PET images before, during, and after radiation treatment.

Who is the study for?
This trial is for adults over 18 with locally advanced esophageal cancer who are about to start radiation therapy lasting more than 4 weeks. Participants must be able to consent and not be pregnant or breastfeeding. They can't have a pacemaker, defibrillator, severe claustrophobia, or issues with Gadolinium contrast used in MRI.Check my eligibility
What is being tested?
The study is testing the use of PET-MRI imaging as part of the treatment process for esophageal cancer patients receiving radiation therapy. It aims to see if incorporating this imaging before, during, and after treatment can improve future care.See study design
What are the potential side effects?
Since this trial involves only imaging procedures like PET-MRI scans and does not include medication or invasive treatments, side effects may include discomfort from lying still during scans or reactions to the Gadolinium contrast agent used in MRI.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of PET-MRI to visualize and assess impact of RT treatments on esophagogastric tumors
Secondary outcome measures
Difference in manual GTV segmentation using PET-MRI
Quantification of dosimetric advantages of PET-MRI treatment plan

Trial Design

1Treatment groups
Experimental Treatment
Group I: PET-MRIExperimental Treatment1 Intervention
PET-MRI in esophagogastric cancers
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PET-MRI
2018
N/A
~100

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,475 Previous Clinical Trials
485,075 Total Patients Enrolled

Media Library

PET-MRI Clinical Trial Eligibility Overview. Trial Name: NCT05796102 — N/A
Esophageal Cancer Research Study Groups: PET-MRI
Esophageal Cancer Clinical Trial 2023: PET-MRI Highlights & Side Effects. Trial Name: NCT05796102 — N/A
PET-MRI 2023 Treatment Timeline for Medical Study. Trial Name: NCT05796102 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to enroll in this research currently available?

"Affirmative, the data hosted on clinicaltrials.gov indicates that this medical study is actively enrolling individuals. Initially posted on March 28th 2023, it seeks 15 participants from a single site."

Answered by AI

How many individuals are being trialled with this medication?

"Affirmative. As per clinicaltrials.gov, this research is open to recruitment with the trial first posted on March 28th 2023 and last revised on April 5th 2023. The study seeks 15 participants from a single location."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
PET-MRI Esophagus Feasibility Study
2023. "PET-MRI Esophagus Feasibility Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05796102.
~7 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top